These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 12556466)
21. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology]. Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576 [TBL] [Abstract][Full Text] [Related]
22. The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms. Cippitelli M; Fionda C; Di Bona D; Lupo A; Piccoli M; Frati L; Santoni A J Immunol; 2003 May; 170(9):4578-92. PubMed ID: 12707336 [TBL] [Abstract][Full Text] [Related]
23. Hepatitis B virus X protein induces expression of Fas ligand gene through enhancing transcriptional activity of early growth response factor. Yoo YG; Lee MO J Biol Chem; 2004 Aug; 279(35):36242-9. PubMed ID: 15173177 [TBL] [Abstract][Full Text] [Related]
24. Activation of MAPK signaling pathway is essential for Id-1 induced serum independent prostate cancer cell growth. Ling MT; Wang X; Ouyang XS; Lee TK; Fan TY; Xu K; Tsao SW; Wong YC Oncogene; 2002 Dec; 21(55):8498-505. PubMed ID: 12466969 [TBL] [Abstract][Full Text] [Related]
25. Early growth response 1 acts as a tumor suppressor in vivo and in vitro via regulation of p53. Krones-Herzig A; Mittal S; Yule K; Liang H; English C; Urcis R; Soni T; Adamson ED; Mercola D Cancer Res; 2005 Jun; 65(12):5133-43. PubMed ID: 15958557 [TBL] [Abstract][Full Text] [Related]
26. Downregulation of c-FLIP sensitizes DU145 prostate cancer cells to Fas-mediated apoptosis. Hyer ML; Sudarshan S; Kim Y; Reed JC; Dong JY; Schwartz DA; Norris JS Cancer Biol Ther; 2002; 1(4):401-6. PubMed ID: 12432255 [TBL] [Abstract][Full Text] [Related]
27. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Unoki M; Nakamura Y Oncogene; 2001 Jul; 20(33):4457-65. PubMed ID: 11494141 [TBL] [Abstract][Full Text] [Related]
28. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines. Klisovic DD; Katz SE; Effron D; Klisovic MI; Wickham J; Parthun MR; Guimond M; Marcucci G Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2390-8. PubMed ID: 12766035 [TBL] [Abstract][Full Text] [Related]
29. EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis. Li L; Ameri AH; Wang S; Jansson KH; Casey OM; Yang Q; Beshiri ML; Fang L; Lake RG; Agarwal S; Alilin AN; Xu W; Yin J; Kelly K Oncogene; 2019 Aug; 38(35):6241-6255. PubMed ID: 31312026 [TBL] [Abstract][Full Text] [Related]
30. The transcription factor Egr1 regulates the HIF-1alpha gene during hypoxia. Sperandio S; Fortin J; Sasik R; Robitaille L; Corbeil J; de Belle I Mol Carcinog; 2009 Jan; 48(1):38-44. PubMed ID: 18506761 [TBL] [Abstract][Full Text] [Related]
31. ID1-, ID2-, and ID3-regulated gene expression in E2A positive or negative prostate cancer cells. Asirvatham AJ; Carey JP; Chaudhary J Prostate; 2007 Sep; 67(13):1411-20. PubMed ID: 17639499 [TBL] [Abstract][Full Text] [Related]
32. Hepatocyte nuclear factor (HNF)-4alpha induces expression of endothelial Fas ligand (FasL) to prevent cancer cell transmigration: a novel defense mechanism of endothelium against cancer metastasis. Osanai M; Chiba H; Kojima T; Fujibe M; Kuwahara K; Kimura H; Satoh M; Sawada N Jpn J Cancer Res; 2002 May; 93(5):532-41. PubMed ID: 12036449 [TBL] [Abstract][Full Text] [Related]
33. Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins. Prabhu S; Ignatova A; Park ST; Sun XH Mol Cell Biol; 1997 Oct; 17(10):5888-96. PubMed ID: 9315646 [TBL] [Abstract][Full Text] [Related]
34. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Bouchard C; Dittrich O; Kiermaier A; Dohmann K; Menkel A; Eilers M; Lüscher B Genes Dev; 2001 Aug; 15(16):2042-7. PubMed ID: 11511535 [TBL] [Abstract][Full Text] [Related]
35. Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143. Li Y; Raffo AJ; Drew L; Mao Y; Tran A; Petrylak DP; Fine RL Cancer Res; 2003 Apr; 63(7):1527-33. PubMed ID: 12670900 [TBL] [Abstract][Full Text] [Related]
36. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis. Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184 [TBL] [Abstract][Full Text] [Related]
37. Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma. Abdulkadir SA; Carbone JM; Naughton CK; Humphrey PA; Catalona WJ; Milbrandt J Hum Pathol; 2001 Sep; 32(9):935-9. PubMed ID: 11567222 [TBL] [Abstract][Full Text] [Related]
38. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells. Wiener Z; Ontsouka EC; Jakob S; Torgler R; Falus A; Mueller C; Brunner T Exp Cell Res; 2004 Sep; 299(1):227-35. PubMed ID: 15302589 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells. Lee SJ; Ha MJ; Lee J; Nguyen P; Choi YH; Pirnia F; Kang WK; Wang XF; Kim SJ; Trepel JB J Biol Chem; 1998 Apr; 273(17):10618-23. PubMed ID: 9553123 [TBL] [Abstract][Full Text] [Related]
40. The Arf-inducing transcription factor Dmp1 encodes a transcriptional activator of amphiregulin, thrombospondin-1, JunB and Egr1. Mallakin A; Sugiyama T; Kai F; Taneja P; Kendig RD; Frazier DP; Maglic D; Matise LA; Willingham MC; Inoue K Int J Cancer; 2010 Mar; 126(6):1403-16. PubMed ID: 19816943 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]